Evidence map›Paper›PMID 39652652›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2024

Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus: International Results from Peritoneal Dialysis Outcomes and Practice Patterns Study.

Karthik K Tennankore, Keith McCullough, Brian Bieber, Yeoungjee Cho, David W Johnson, Talerngsak Kanjanabuch, Hideki Kawanishi, Yong-Lim Kim, Mark Lambie, Claudio Rigatto and 4 more

Abstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Observational
  5. Article
  6. Longitudinal Trajectories of CKD-Associated Pruritus.Kidney international reports · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Karthik K TennankoreDepartment of Medicine, Dalhousie University, Nova Scotia Health, Halifax, Nova Scotia, Canada.ORCID 0000-0002-7919-6709
Keith McCulloughArbor Research Collaborative for Health, Ann Arbor, Michigan.ORCID 0000-0003-1995-1888
Brian BieberArbor Research Collaborative for Health, Ann Arbor, Michigan.ORCID 0000-0001-8505-0979
Yeoungjee ChoDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID 0000-0002-3502-9837
David W JohnsonDepartment of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID 0000-0001-5491-3460
Talerngsak KanjanabuchDivision of Nephrology, Department of Medicine and Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0002-2996-8934
Hideki KawanishiDepartment of Artificial Organs, Tsuchiya General Hospital, Hiroshima, Japan.ORCID 0000-0002-1207-0888
Yong-Lim KimDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea.ORCID 0000-0002-1344-3455
Mark LambieSchool of Medicine, Keele University, Stoke on Trent, United Kingdom.ORCID 0000-0002-6285-5368
Claudio RigattoChronic Disease Innovation Centre, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-8306-8072
Jenny ShenThe Lundquist Institute at Harbor-UCLA Medical Center Torrance, CA.ORCID 0000-0002-2993-403
Martin SchreiberVP Clinical Integration, DaVita Integrated Kidney Care, Denver, Colorado.
Jeffrey PerlDivision of Nephrology, Department of Medicine, St. Michael's Hospital, Unity Health, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-0008-7623
Ronald L PisoniArbor Research Collaborative for Health, Ann Arbor, Michigan.

Funding

CSL Behring,Amgen, Akebia Therapeutics, Astellas Pharma US, Bard Peripheral Vascular, Inc., Baxter Healthcare Corporation, Bayer Yakuhin, Bayer, Cara, Chugai Pharmaceutical, GlaxoSmithKline, Japanese Society for Peritoneal Dialysis, JMS Co., LTD, Kidney Foundation, Japan, Kissei, Kyowa Hakko Kirin, Merck Sharp and Dohme K.K.,Nikkiso Co,. LTD, no Pharmaceutical, Terumo, Torii Pharmaceutical, Vifor Pharma, National Institutes of Health Agency for Healthcare Research and Quality
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39652652
PMCPMC11637705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.